Moreover, several other CXCR4 antagonists are currently in clinical trials for cancer, HIV and WHIM syndrome treatment, highly supporting its potential use for the treatment of CPSP in clinic (Debnath et al., 2013). Here, CXCR4 is linked to WHIM syndrome.